AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 6 |
Market Cap | 438.71M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 0.02 |
PE Ratio (ttm) | 349 |
Forward PE | n/a |
Analyst | Buy |
Ask | 8 |
Volume | 236,567 |
Avg. Volume (20D) | 190,652 |
Open | 6.50 |
Previous Close | 6.44 |
Day's Range | 6.40 - 7.07 |
52-Week Range | 5.71 - 14.05 |
Beta | undefined |
About BIOX
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides...
Analyst Forecast
According to 4 analyst ratings, the average rating for BIOX stock is "Buy." The 12-month stock price forecast is $13, which is an increase of 86.25% from the latest price.
Next Earnings Release
Analysts project revenue of $144.62M, reflecting a 3.08% YoY growth and earnings per share of 0.15, making a 650.00% increase YoY.
2 months ago · seekingalpha.com
Bioceres Is Getting Cheaper, Not Yet An Opportunity But More InterestingBioceres' 1Q25 results were challenging due to adverse weather in Argentina, affecting crop nutrition, protection, and seeds, but potential recovery is expected in 2Q25. BIOX has depreciated significa...
2 months ago · seekingalpha.com
Bioceres Crop Solutions Corp. (BIOX) Q1 2025 Earnings Call TranscriptBioceres Crop Solutions Corp. (NASDAQ:BIOX ) Q1 2025 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Paula Savanti – Head-Investor Relations Federico Trucco – Chief Executiv...